Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Results of the Phase 2 Trial on Retatrutide for Obesity Retatrutide's Phase 2 clinical trial results were published in The New England Journal of Medicine
Women who were obese and had taken GLP-1 drugs were 30% less likely to get diagnosed with breast cancer, compared with other women who hadnt taken these medications, according to a new study published in the medical journal, JCO Oncology Practice
Treatment Suitability** - The clinic reserves the right to refuse or reschedule treatments if the patient is deemed unsuitable based on medical assessment, contraindications, or other relevant factors
No documented interactions contraindicate combined use, and the distinct pathways suggest potential synergy
Timing consistency during titration is critical
